Helping healthy cells could be key to fighting leukemia, research suggests

Researchers at Imperial College London have shown that keeping healthy blood cells alive could be a more important tool in the fight against leukaemia than keeping cancerous cells at bay.

The team used computer modelling to show that maintaining a friendly environment for healthy cells was more effective than targeting the damaged cells directly. This result could change the way is treated, as has traditionally relied on fighting disease rather than maintaining health.

A better understanding of the processes taking place in the bone marrow could therefore allow doctors to take earlier and more targeted action in combating leukaemia.

A cancer of the blood, leukaemia is thought to survive and grow through the action of leukaemia stem cells (LSCs), which multiply within the bone marrow. Here they face competition for resources with haematopoietic stem cells (or HSCs), which are responsible for producing and maintaining all the different varieties of healthy blood cell within the body.

The paper, published in the Journal of the Royal Society Interface today, is the first attempt to model competition between these two types of cells using methods borrowed from the world of ecology.

Lead author Adam MacLean said: "The first researchers to model competing populations mathematically were looking at predators and prey - famously lynx hunting wild hares. Whilst we don't have predator and prey cells, we have two cellular species who directly compete against each other for resources, and our models analyse how that competition plays out within the biological niche of the ."

The team carried out to find conditions that would result in vanishing numbers of leukaemia cells. They found that the greatest chance of beating leukaemia came from maintaining a healthy population of HSCs, rather than trying to eradicate the LSCs directly.

According to Michael Stumpf, Professor of Theoretical and one of the paper's co-authors, "maintaining health is more likely to eradicate leukaemia than fighting leukaemia directly without taking care of the healthy . And that's a slightly surprising result which nobody had explicitly stated before. It allows us to understand these processes in a way that could be important for potential therapeutic responses."

Thanks to a recent funding grant from blood cancer charity Leukaemia & Lymphoma Research, Dr Lo Celso and her team hope to refine the models outlined in the paper to more accurately simulate conditions in the human body.

Professor Stumpf added: "We want to make the model more useful, and find cases where we can break the model if it's incorrect. Its simplicity means that it's fairly robust, but we hope to reproduce the real complexity of the competition between HSCs and LSCs."

Related Stories

An unexpected way to cause leukemia

date Apr 07, 2008

Leukaemia – cancer of blood or bone marrow – is caused by mutations that allow defective blood cells to accumulate and displace healthy blood. To devise effective therapies it is crucial to know which mutations cause ...

Scientists discover cells critical to childhood leukemia

date Jan 21, 2010

Scientists at The Royal Melbourne Hospital and the University of Melbourne in Australia have discovered the cells that cause a common type of childhood leukaemia - T cell Acute Lymphoblastic Leukaemia (T-ALL). Targeting of ...

Recommended for you

DNA blood test detects lung cancer mutations

date 15 hours ago

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers ...

Tumors prefer the easy way out

date 17 hours ago

Tumor cells become lethal when they spread. Blocking this process can be a powerful way to stop cancer. Historically, scientists thought that tumor cells migrated by brute force, actively pushing through whatever ...

Brain tumors may be new targets of Ebola-like virus

date 17 hours ago

Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers—portions of a deadly virus similar to Ebola.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.